Campbell & CO Investment Adviser LLC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$270,000
+64.6%
40,358
+211.5%
0.06%
-39.0%
Q4 2020$164,00012,9540.10%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 2,610$620,000,0006.47%
Parkman Healthcare Partners LLC 1,124,072$4,732,0001.74%
Kynam Capital Management, LP 1,000,000$4,210,0001.08%
EAM Investors, LLC 850,647$3,581,0000.87%
BVF INC/IL 3,629,000$15,278,0000.74%
EAM Global Investors LLC 388,730$1,637,0000.40%
RA Capital Management 3,307,203$13,923,0000.37%
Nantahala Capital Management 1,659,840$6,988,0000.35%
AWM Investment Company, Inc. 504,661$2,125,0000.34%
INGALLS & SNYDER LLC 1,411,153$5,941,0000.31%
View complete list of CONCERT PHARMACEUTICALS INC shareholders